A research team led by Zhiping Weng, Ph.D., and Jill Moore, Ph.D."18, at UMass Chan Medical School, has nearly tripled the ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
Non-coding DNA is essential for both humans and trypanosomes, despite the large evolutionary divergence between these two species.
This Research Topic invites high-impact research that advances nanotechnology-enabled antiviral interventions across the pipeline from molecular design to ...
MIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from ...
According to a Westlake Corp. news release on Monday, operations will cease at the following facilities before the end of the year: A polyvinyl chloride plant at the Aberdeen, Miss. site, which has an ...
Houston chemical maker to close 3 plants and lay off hundreds of workers due to ‘challenging market’
Houston-based Westlake Corporation is closing three of its Louisiana plants, citing difficult market conditions. Operations will end this month, and the closures will eliminate positions for around ...
A thick layer of more than 12 miles of rock may explain why Bermuda seems to float above the surrounding ocean. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...
Shares of Structure Therapeutics Inc. (NASDAQ: GPCR) are soaring Monday after the clinical-stage biopharmaceutical company reported positive topline data from a weight loss drug trial. The positive ...
Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...
Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial intelligence to accelerate the development and testing of small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results